Acute pancreatitis (AP), as a common kind of pancreas-based inflammatory disease, is accompanied by a serious and abnormal metabolism. However, the specific metabolic process of AP is still unclear. Novel and effective drugs against acute pancreatitis are urgently required. To explore the metabolic biomarkers and regulation pathways of acute pancreatitis, ultra-performance liquid chromatography (UPLC) combined with a mass spectrometry (MS)-based metabolomics strategy was used. Sixteen male adult SpragueDawley rats were divided into two groups: a sham operation group (SO) and an AP model group. The AP animal model was induced via the retrograde ductal infusion of 3.5% sodium taurocholate, and rats in the SO group were infused with 0.9% saline. After serum sample collection and sacrifice, a metabolomics strategy based on UPLC-MS was used to detect serum metabolites and metabolic pathways by comparing the SO and AP model groups through full-scan analysis. A total of 19 metabolites were detected in the serum for highlighting the differences between the two groups: L-arabitol, citric acid, isocitric acid, Lphenylalanine, L-tyrosine, dihydroxyacetone, L-valine, succinic acid, 3-hydroxybutyric acid, uric acid, acetylglycine, palmitic amide, homocysteine, D-glutamine, L-arginine, arachidonic acid, N-acetylserotonin, (R)-3-hydroxy-hexadecanoic acid, and D-mannose. Six crucial metabolic pathways, phenylalanine, tyrosine and tryptophan biosynthesis, arachidonic acid metabolism, glyoxylate and dicarboxylate metabolism and the citrate cycle, were involved; these have potential to become novel targets for the treatment of AP. The ingenuity pathway analysis (IPA) platform is used to gain insights into the metabolic targets in the system, referring to development disorders, cell-to-cell signaling and interactions, cellular assembly and organization, cell compromise, cell growth and proliferation, carbohydrate metabolism and others. It is suggested that UPLC-MS-based metabolomics is capable of accurately depicting the pathological mechanisms of acute pancreatitis, which can drive new drug development.
Introduction
As one of main culprits behind autodigestive disorders threatening human health in recent years, acute pancreatitis (AP) is induced by the inammation of the exocrine part of the pancreas, where digestive enzymes are secreted into the duodenum.
1,2 Some of the main symptoms in patients are abdominal pain, back pain, a tender abdomen, increased heart rate, nausea and vomiting, fever and weight loss.
3 Recent studies from the United States report that approximately 15-40 cases of AP are conrmed per 100 000 inhabitants, which is an increase over recent years. 4, 5 It can lead to multiple organ failure, such as renal and cardiovascular failure, as well as respiratory failure. 6 According to the severity of the symptoms, the pathogenetic conditions of AP can either improve or aggravate within several days. Almost four-hs of AP patients without serious morbidity can be treated. If undiagnosed or misdiagnosed, it causes the death of the patient due to multiple organ failure. 7 It can be seen that early diagnosis and early prevention are of great signicance in the control of AP. 8 However, the pathogenesis of AP is still unclear, in relation to premature intracellular protease activation and other developments, such as oxidative stress. 9, 10 Currently, AP diagnosis depends on standard laboratory tests and radiological imaging, such as ultrasound, MRI and CT scans, and then uid and nutrient replenishment, and pancreatic protease inhibitors are usually adopted in clinical practice. [11] [12] [13] Owing to the invasive, risky, and time-consuming nature of these procedures, many individuals at risk for AP have not been effectively screened in time. The metabolic environment of patients can be affected by pathological damage, leading to difficulties in early diagnosis and treatment.
14 It is necessary to gain insight into the pathomechanism of AP at a metabolic level before seeking out novel drugs against AP and associated systemic conditions.
Metabolomics is devoted to unscrambling the characteristics and interactions of low molecular weight endogenous metabolites in a biological sample, such as tissue, or a bodily uid, such as blood. 15 In the human body, there are far fewer metabolites (about 4000) than genes or proteins. The metabolome represents a magnifying glass highlighting biological processes of cells occurring in the body, which are involved in anabolism, catabolism, absorption, distribution, the detoxi-cation of natural and xenobiotic materials, and energy utilization.
16
Genomic and protein-related information is not completely dependent on endogenous and exogenous factors, such as enzymatic, pathological, environmental, and lifestyle factors, but alterations in metabolite levels have the ability to better reect the functional status of cells because they occur downstream of DNA, RNA, and protein alterations. 17 Compared with other omics, metabolomics, as a high-resolution and highthroughput research method, is considered to be an accessible approach for exploring diagnostic biomarkers at this stage; this is ascribed to the evolution of analytical technologies and soware tools for data processing and statistics. In recent years, NMR, LC-MS and gas chromatography-mass spectrometry (GC-MS) metabolic techniques have attained widespread use as analysis methods.
18 MS-based metabolomics possesses higher sensitivity, which means that there is the chance to survey a generally large number of small molecules. However, it adds the risk of generating technical artifacts and uncertainty in measurements. A combination of different metabolomics techniques could lead to the obtaining of comprehensive and sufficient metabolite information from intricate biological samples. 19 It has been suggested that metabolite proling is a promising tool for AP diagnosis, disease staging, the detection of phenotypes, prognosis prediction, predicting the onset of disease, and developing new drugs. [20] [21] [22] [23] In this study, a serum metabolomics strategy based on UPLC-MS combined with multivariate data methods and pathway analysis was used to seek therapeutic targets for AP aer the retrograde ductal infusion of 3.5% sodium taurocholate to rats. In addition, histological examinations and biochemical indices assist in elucidating the establishment of an AP model.
Methods

Ethics statement
The study protocol was approved by the Ethics Committee for Animal Experiments of BeiJing University. All rats were handled in light of the University Guidelines and the Animal Care Committee Guidelines of Qiqihar Medical University. All operations were performed under chloral hydrate anesthesia, and all efforts were made to minimize suffering. 
Chemicals and reagents
Chromatographic grade chemicals including methanol, acetonitrile and formic acid were purchased from Sigma-Aldrich (St. Louis, MO, USA) and Honeywell Company (Morristown, New Jersey, USA). The distilled water used for preparing all the aqueous solutions and mobile phases was obtained from Watson's Food & Beverage Co. Ltd (Guangzhou, China). Leucine enkephalin with a purity >99% was obtained from SigmaAldrich (St. Louis, MO, USA). Isourane and physiologic saline solution were purchased from a drugstore (Harbin, China). The assay kits for serum amylase, tumor necrosis factor-alpha (TNFalpha), interleukin-6 (IL-6), myeloperoxidase (MPO), malondialdehyde (MDA) and superoxide dismutase (SOD) activities were all purchased from Wako Pure Chemical Industries Ltd (Osaka, Japan).
Animal model of acute pancreatitis
Six weeks old healthy male adult Sprague-Dawley (SD) rats weighing 200 AE 20 g were purchased from the Animals Experimentation Center of the BeiJing University of Chinese Medicine. All rats were maintained in an air-conditioned animal room at an appropriate temperature of 22 AE 2 C and a relative humidity of 60 AE 5%, which provides 12 h diurnal cycles. Before the experiments, the animals are acclimated for one week with special feed and tap water. Sixteen rats were randomly allocated to two groups, with 8 rats in each group as follows: a sham operation (SO) group and an AP model group. It was reported that the retrograde ductal infusion of sodium taurocholate is a common way to induce AP. Animals fasted for 12 h and were offered free access to tap water before the operation. All rats were drugged via the intraperitoneal injection of 3 mL kg À1 10% chloral hydrate. Firstly, the hepatic duct was closed using a small bulldog clamp, and then the biliopancreatic duct was cannulated through the offside of the front opening of the duodenum papilla. 1 mL kg À1 3.5% sodium taurocholate was used for the retrograde pancreaticobiliary duct injection of rats in the AP model group using an infusion pump, whereas rats in the SO group were subject to the same operation with 1 mL kg À1 0.9% saline.
Aer operation, the animals were also infused with physiologic saline solution for reviviscence.
Histological examinations and biochemical indices
Twelve hours aer model establishment, the two groups of rats were injected with 4% pentobarbital sodium (0.3 mL/100 g body weight). 5 mL heparinized blood samples were obtained from the angular vein and centrifuged at 3500 rpm for 15 min at 4 C.
The serum supernatant was collected and stored immediately at À80 C. The serum amylase, tumor necrosis factor-alpha (TNFalpha), interleukin-6 (IL-6), myeloperoxidase (MPO), malondialdehyde (MDA) and superoxide dismutase (SOD) activities were determined according to the manufacturer instructions using assay kits. Pancreatic tissue was immediately removed and immersed in 10% formalin neutral buffer solution for H&E analysis aer xation, embedding in paraffin, and sectioning.
Aer the experiments, the rats were sacriced and cremated. Aer reconstitution using an extraction buffer including 20% acetonitrile, 40% methanol and 40% water, the dried sample was centrifuged again at 12 000 rpm and 4 C for 15 min to remove ne particulate matter. 2 mL of supernatant was transferred to a glass vial for injection for UPLC-MS analysis. 2.5.2 LC-MS conditions. Chromatographic analysis was performed using a Waters Acquity TM Ultra Performance LC system (Waters, Milford, USA), which was equipped with a pump, an autosampler and a 0.17 mm ACQUITY BEH C 18 chromatography column. Mass spectrometry was performed using a Waters Synapt TM HDMS (Waters, Milford, USA), equipped with positive ionization mode (ESI+) and negative ionization mode (ESIÀ) sources for sample analysis. A quality control (QC) sample, characterized by its ability to check basic information related to the chromatography column, was used; it seemed a salient sample, as it involved all of the compounds of the sample to be analyzed.
The optimizing mobile chromatography phase consisted of (A) acetonitrile with 0.15% formic acid and (B) water with 0.15% formic acid. The elution gradient conditions were set to the following: 0-1 min, 2-10% A; 1-2.5 min, 10-20% A; 2.5-5 min, 20-45% A; 5-6 min, 45-60% A; 6-9 min, 60-83% A; 9-11 min, 83-100%A; 11-13 min, 100% A; and 13-15 min, 100-2% A. 2 mL of sample solution was injected for separation and the column temperature was held at 30 C with a ow rate of 0.4 mL min À1 .
Then, the obtained elution was promptly transferred to the MS system before splitting. The cone voltage was 45 V and 35 V in positive and negative mode, respectively. 100-2000 m/z scan data were acquired with a 0.2 s scan time and a 0.1 s inter-scan delay over a 15 min run-time. In positive mode, the capillary voltage was set to 3.5 kV, and the capillary voltage was set to 2.8 kV in negative mode. The MS source temperature was set to 110 C, and the desolvation gas temperature was set to 350 C under a desolvation gas ow of 50 L h À1 . 0. For data dimension reduction and matrix acquisition, the raw UPLC-MS data was processed using Progenesis QI soware v1.0 (Nonlinear Dynamics, Newcastle, U.K.). The retention time and m/z data pair for each peak was collected, and then each ion intensity from each detected peak was normalized to the sum of the peak intensities, which provides the peak code, m/z value and normalized intensity. 
Results
Histological and biochemical analysis
The movement of rats in the model group was slower than that of the control rats. In a histopathological examination with H&E staining, it was shown that the pancreatic tissue of model rats was observed to show severe edema, acinar cell degeneration, and moderate inammation compared with the control mice. The serum amylase activity and levels of TNF-a, IL-6, MPO and MDA in rats were signicantly increased in the model group (p < 0.01). Compared with the control rats, the levels of SOD in the serum of the AP mice were lower (p < 0.05). The results suggested that the condition of the pancreatic tissue became worse and worse as time went on, which led to reduced immunity in the model rats (Fig. 1 ).
Multivariate statistical analysis
Every group of serum samples was collected and analyzed under the optimal UPLC-MS conditions mentioned above. Aer Progenesis QI manipulation, 9892 peaks and 8042 peaks were discerned as positive ion (ESI+) peaks and negative ion (ESIÀ) peaks, respectively. As shown in Fig. 2 , each point stands for an individual sample in the PCA score plot. The metabolic proles of the model group were separated evidently from those of the control group, which revealed that serum metabolites in the AP rats do not demonstrate normal levels. Then, more sophisticated OPLS-DA was performed to explore whether the differentially expressed metabolites were responsible for the separation between the control group and the model group. In  Fig. 3 , the ions furthest away from the origin may be considered as the differentiating metabolites in the corresponding S-plot. The acquired VIP-plots closely relate to potential biomarker screening using the variation and correlation contributions, through which differentially expressed metabolites ions were selected using VIP values of more than 1 and p values of less than 0.05 from Student's t-test analysis.
Potential biomarker analysis
MS/MS information from differentially expressed metabolites ions was collected. With the help of biochemical online databases, such as MetaboAnalyst, LIPID MAPS, HMDB, MassBank and METLIN, possible chemical compositions and presumed molecular formulas were collected. As shown in Table 1 , a total of 19 metabolites were tentatively proposed as potential biomarkers to interpret the separation between the control and model groups: includes L-arabitol, citric acid, isocitric acid, Lphenylalanine, L-tyrosine, dihydroxyacetone, L-valine, succinic acid, 3-hydroxybutyric acid, uric acid, acetylglycine, palmitic amide, homocysteine, D-glutamine, L-arginine, arachidonic acid, N-acetylserotonin, (R)-3-hydroxy-hexadecanoic acid, and Dmannose. As shown in Fig. 4 , ve metabolites were decreased in the AP rats compared with the control rats, and fourteen metabolites were increased.
Potential metabolic pathway analysis
MetPA is a free web-based tool with pathway topology analysis based on the MetaboAnalyst platform. The pathogenesis of AP mainly involves the following pathways: phenylalanine, tyrosine and tryptophan biosynthesis, phenylalanine metabolism, valine, leucine and isoleucine biosynthesis, arachidonic acid metabolism, glyoxylate and dicarboxylate metabolism and the citrate cycle (TCA cycle), whose p values are 1.000, 0.4071, 0.3330, 0.3260, 0.2960 and 0.1205, respectively (Fig. 5) . The KEGG global metabolic network, which portrays metabolites and enzymes/KEGG orthologs, is shown in Fig. 6 and is associated with 9 metabolites and 10 pathways. The metabolitemetabolite interaction network involved citric acid, L-tyrosine, Lphenylalanine, isocitric acid, L-valine, succinic acid, L-arginine, homocysteine, arachidonic acid, uric acid, and D-mannose, and is extruded in line with reactions involving similar chemical structures and molecular activities, as shown in Fig. 7 . Then, IPA was utilized to further decipher ingenuity pathway data involving detailed changes in complex data; this indicated that AP pathogenesis is mainly associated with development disorder, cell-to-cell signaling and interactions, cellular assembly and organization, cell compromise, cell growth and proliferation, carbohydrate metabolism and others (Fig. 8) . 
Discussion
Pancreatic duct reex caused by pancreaticobiliary reux is one of the main causes of AP, which does harm to the pancreatic duct. A large amount of pancreatic enzymes in the pancreas are activated and released in advance to cause inammation. At the same time, activated various inammatory cytokines, tumor necrosis factors, and oxidative stress species enter the pancreas, leading to the activation of proinammatory mediators, which sequentially damage pancreatic cells and surrounding tissues, even leading to multiple organ failure and death. 24 At present, the release of inammatory factors promotes the apoptosis of pancreatic cells, and the reduction in the apoptosis of pancreatic cells aer AP has become one of the current research hotspots in many pathogenesis analyses of AP.
25,26
The selection of animal species and the method of model preparation play important roles in this type of research. A druginduced AP rat model is superior to a mouse model in terms of stability and the degree of pancreatic lesion homogeneity, and rats are also more convenient when it comes to monitoring hemodynamics and organ function. 27 In recent years, it has become easier to prepare animal models of transgenic and knockout mice with the rapid development of genetic modication technology, which makes it more conducive to verify the regulation of key genes in terms of AP, but the sensitivity of different strains of mice to AP remains different.
28
At present, the retrograde injection of sodium taurocholate (ST) into the pancreatic bile tract, invented by Aho HJ, is the most commonly used AP induction method. 29 Sodium taurocholate is one of the main components of two kinds of bile acids in the body. The retrograde injection of sodium taurocholate mainly simulates acute pancreatitis caused by bile reux in the lower obstruction of the common bile duct; it is required to implant the plastic tube of the pancreaticobiliary tube through the duodenal papilla opening. ST is injected through the plastic tube, and the pancreatic cells immediately demonstrate edema, hemorrhage and necrosis within 24 hours. This is complex and traumatic, and the duodenum is then cut into a puncture tube to reduce the risk of intestinal damage and bleeding over time. It has been reported that the oxidative stress and NO synthase regulation patterns in the pancreatic tissue of rats subject to direct pancreatic duct ligation (PDL) are similar to those seen during human pancreatitis, suggesting that the PDL-induced rat pancreatitis model is a promising model for studying the development of human acute pancreatitis. 30 The retrograde injection AP model is reliable, but the severity and repeatability of AP is highly dependent on the perfusion concentration, perfusion pressure, perfusion volume, and time. It is more suitable for etiology studies than for therapeutic studies. In addition, there are pancreatic subcapsular injection, L-arginine injection, cerulein injection, and bile-free ethionine feeding approaches.
31
Metabolomics tools play an important role in researching metabolic disorders and metabolism-related diseases, [32] [33] [34] [35] in the discovery and identication of biomarkers [36] [37] [38] [39] and in investigating responses to treatment. [40] [41] [42] [43] [44] [45] [46] [47] [48] A signicant increase in serum amylase for 12 hours in the rats, revealed by serological examination, demonstrated that serum amylase is strongly activated. At the same time, the release of cytokines into circulation during acute severe pancreatitis was detected. The results showed that the levels of inammatory factors, such as tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6), are signicantly elevated in the AP group of rats. In the oxidative stress system analysis, an increase in the cytokines MPO and MDA, which promote oxidative stress in AP rats, and a decrease in the cytokine SOD, which attenuates oxidative stress, indicated that the model rats were in an oxidative stress-enhancing state. 49, 50 This is one of the causes of secondary tissue damage. The above results were similarly veried from pathological analysis of sections of pancreas. The stress state can change the free amino acid content in the body, and an enhancement in skeletal muscle protein degradation is one of the important factors leading to the redistribution of amino acids in the blood. The Phe/Try ratio is a sensitive indicator of skeletal muscle protein degradation. Phe and Try levels in the model group were signicantly higher than in the control group, suggesting that the plasma amino acid prole changes and protein breakdown occurs in skeletal muscle. The study found that for a higher Phe/ Try ratio, the skeletal muscle protein breakdown may be faster, and skeletal muscle consumption is most pronounced. From the perspective of energy metabolism, it should be noted that energy supply to the body to prevent the excessive decomposition of protein should be paid attention to in the early treatment of AP. 51, 52 Proline, leucine and isoleucine contain large hydrophobic side chains, and their rigid structural features and hydrophobic interactions have an important inuence on protein folding. In this study, it was found that the synthesis of proline, leucine and isoleucine was impeded, indicating that the protein production pathway was hampered, which is similar to the pathological mechanism of pancreatitis. Arachidonic acid metabolites include prostaglandins and leukotrienes, both of which are cleavable by arachidonic acid under the action of PLA2. Arachidonic acid is converted to prostacyclin (PGI2) and hemagglutinin A2 (TXA2) under the catalysis of cyclooxygenase. PGI2 is a potent platelet aggregation inhibitor and vascular relaxant, and TXA2 is the strongest platelet aggregation agent and vasoconstrictor. The opposite effects of PGI2 and TXA2 maintain an equilibrium, which is an important physiological function of the body that can control the normal hemostasis mechanism. The content of arachidonic acid in the model group increased, leading to the imbalance between PGI2 and TXA2. Leukotriene produced by another metabolic pathway of arachidonic acid has biological effects, such as increased capillary permeability, contracted blood vessels, and neutrophil chemotaxis. It is also the main cause of pancreatic pain in AP patients. Amino acid metabolism and arachidonic acid metabolism have the potential to be seen as novel targets for the treatment of AP. 53 
Conclusions
The characteristics of the serum metabolomic prole discrepancies between AP and SO rats were found. L-Arabitol, citric acid, isocitric acid, L-phenylalanine, L-tyrosine, dihydroxyacetone, Lvaline, succinic acid, 3-hydroxybutyric acid, uric acid, acetylglycine, palmitic amide, homocysteine, D-glutamine, L-arginine, arachidonic acid, N-acetylserotonin, (R)-3-hydroxy-hexadecanoic acid, and D-mannose may be seen as potential biomarkers of AP morbidity, which contribute further understanding to the pathophysiology and metabolic state. Amino acid metabolism and arachidonic acid metabolism contribute to the evaluation of a holistic mechanism and the search for new drugs for AP. The UPLC-MS based metabolomics method was able to offer novel and non-invasive methodology for AP research in the medical world.
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